These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 34170813)
1. Synergistic Role of Thymoquinone on Anticancer Activity of 5-Fluorouracil in Triple Negative Breast Cancer Cells. Zheng M; Mei Z; Junaid M; Tania M; Fu J; Chen HC; Khan MA Anticancer Agents Med Chem; 2022; 22(6):1111-1118. PubMed ID: 34170813 [TBL] [Abstract][Full Text] [Related]
2. Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells. Adinew GM; Messeha SS; Taka E; Badisa RB; Antonie LM; Soliman KFA Nutrients; 2022 May; 14(10):. PubMed ID: 35631261 [TBL] [Abstract][Full Text] [Related]
3. Thymoquinone, a bioactive component of black caraway seeds, causes G1 phase cell cycle arrest and apoptosis in triple-negative breast cancer cells with mutant p53. Sutton KM; Greenshields AL; Hoskin DW Nutr Cancer; 2014; 66(3):408-18. PubMed ID: 24579801 [TBL] [Abstract][Full Text] [Related]
4. Thymoquinone upregulates IL17RD in controlling the growth and metastasis of triple negative breast cancer cells in vitro. Khan MA; Zheng M; Fu J; Tania M; Li J; Fu J BMC Cancer; 2022 Jun; 22(1):707. PubMed ID: 35761256 [TBL] [Abstract][Full Text] [Related]
5. Enhanced in vitro tumoricidal effects of 5-Fluorouracil, thymoquinone, and active vitamin D Idris S; Refaat B; Almaimani RA; Ahmed HG; Ahmad J; Alhadrami M; El-Readi MZ; Elzubier ME; Alaufi HAA; Al-Amin B; Alghamdi AA; Bahwerth F; Minshawi F; Kabrah SM; Aslam A Life Sci; 2022 May; 296():120442. PubMed ID: 35245520 [TBL] [Abstract][Full Text] [Related]
6. Thymoquinone Increases the Sensitivity of SW-480 Colon Cancer Cells to 5-Fluorouracil. Zeinali N; Mahmoudzadeh V; Anarjani A; Ebrahimnejad M; Yousefi B; Valizadeh A Biomed Res Int; 2024; 2024():6231095. PubMed ID: 39015603 [No Abstract] [Full Text] [Related]
7. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3. Ünal TD; Hamurcu Z; Delibaşı N; Çınar V; Güler A; Gökçe S; Nurdinov N; Ozpolat B Anticancer Agents Med Chem; 2021; 21(3):355-364. PubMed ID: 32767958 [TBL] [Abstract][Full Text] [Related]
8. In Vitro Assessment of the Cytotoxic Effect of 5-Fluorouracil, Thymoquinone and their Combination on Tongue Squamous Cell Carcinoma Cell Line. Eloraby DAI; El-Gayar SF; El-Bolok AH; Ammar SG; ElShafei MM Asian Pac J Cancer Prev; 2024 Jun; 25(6):2169-2176. PubMed ID: 38918680 [TBL] [Abstract][Full Text] [Related]
9. Modulation of gene expression by thymoquinone conjugated zinc oxide nanoparticles arrested cell cycle, DNA damage and increased apoptosis in triple negative breast cancer cell line MDA-MB-231. Sjs B; K K; A P; P H; B SR; S S Drug Dev Ind Pharm; 2021 Dec; 47(12):1943-1951. PubMed ID: 35510706 [TBL] [Abstract][Full Text] [Related]
10. Thymoquinone Anticancer Effects Through the Upregulation of NRF2 and the Downregulation of PD-L1 in MDA-MB-231 Triple-Negative Breast Cancer Cells. Adinew G; Messeha SS; Badisa R; Taka E; Soliman KFA FASEB J; 2022 May; 36 Suppl 1():. PubMed ID: 35723877 [TBL] [Abstract][Full Text] [Related]
11. Effects of 5-fluorouracil, thymoquinone, and mammary stem cells' exosomes on Abdelfattah-Hassan A; Ibrahim D; Saleh AA; Kishawy ATY; Mohamed RHA; Khater SI Open Vet J; 2024 Jan; 14(1):525-533. PubMed ID: 38633189 [TBL] [Abstract][Full Text] [Related]
12. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer. Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628 [TBL] [Abstract][Full Text] [Related]
13. Thymoquinone inhibits growth and augments 5-fluorouracil-induced apoptosis in gastric cancer cells both in vitro and in vivo. Lei X; Lv X; Liu M; Yang Z; Ji M; Guo X; Dong W Biochem Biophys Res Commun; 2012 Jan; 417(2):864-8. PubMed ID: 22206670 [TBL] [Abstract][Full Text] [Related]
14. The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer. Şakalar Ç; İzgi K; İskender B; Sezen S; Aksu H; Çakır M; Kurt B; Turan A; Canatan H Tumour Biol; 2016 Apr; 37(4):4467-77. PubMed ID: 26500095 [TBL] [Abstract][Full Text] [Related]
15. Effect of thymoquinone on pharmacokinetics of 5-fluorouracil in rats and its effect on human cell line Eftekhar SP; Kazemi S; Moghadamnia AA Hum Exp Toxicol; 2022; 41():9603271221145422. PubMed ID: 36510676 [TBL] [Abstract][Full Text] [Related]
16. TQFL12, a novel synthetic derivative of TQ, inhibits triple-negative breast cancer metastasis and invasion through activating AMPK/ACC pathway. Wei C; Zou H; Xiao T; Liu X; Wang Q; Cheng J; Fu S; Peng J; Xie X; Fu J J Cell Mol Med; 2021 Nov; 25(21):10101-10110. PubMed ID: 34609056 [TBL] [Abstract][Full Text] [Related]
17. Hijacking 5-Fluorouracil Chemoresistance in Triple Negative Breast Cancer via microRNAs-Loaded Chitosan Nanoparticles. Fahmy SA; Mahdy NK; Mohamed AH; Mokhtar FA; Youness RA Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396746 [TBL] [Abstract][Full Text] [Related]
18. Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer. Barkat MA; Harshita ; Ahmad J; Khan MA; Beg S; Ahmad FJ Curr Drug Targets; 2018; 19(1):70-80. PubMed ID: 28606050 [TBL] [Abstract][Full Text] [Related]
19. Thymoquinone subdues tumor growth and potentiates the chemopreventive effect of 5-fluorouracil on the early stages of colorectal carcinogenesis in rats. Kensara OA; El-Shemi AG; Mohamed AM; Refaat B; Idris S; Ahmad J Drug Des Devel Ther; 2016; 10():2239-53. PubMed ID: 27468227 [TBL] [Abstract][Full Text] [Related]
20. Establishment of a 5-fluorouracil-resistant triple-negative breast cancer cell line. Takahashi K; Tanaka M; Inagaki A; Wanibuchi H; Izumi Y; Miura K; Nagayama K; Shiota M; Iwao H Int J Oncol; 2013 Dec; 43(6):1985-91. PubMed ID: 24126575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]